COPD News

WASHINGTON — In patients with COPD, pulmonary rehabilitation conducted remotely led to improvements in depression and quality of life, according to an abstract presented at the American Thoracic Society International Conference.

WASHINGTON — Patients with severe emphysema had improved lung function at 5 years after receiving treatment with a support expiration valve system, according to research presented at the American Thoracic Society International Conference.

WASHINGTON — Compared with other hypnotics, a class of insomnia hypnotics did not raise the risk for death or inpatient COPD exacerbations, according to research presented at the American Thoracic Society International Conference.

WASHINGTON — Over 12 or 24 weeks, patients with COPD receiving ensifentrine showed improved measures of lung function, quality of life and exacerbation rate, according to an American Thoracic Society International Conference presentation.

WASHINGTON — Among 30 women with advanced COPD, many reported barriers to care and none received palliative care, according to an abstract presented at the American Thoracic Society International Conference.

WASHINGTON — All-cause mortality rates in patients with COPD rose when they had mucus plugs blocking medium- to large-sized airways, according to a study presented at the American Thoracic Society International Conference.

Patients with COPD first visiting the ED with acute exacerbations faced greater risks for dementia with ICU admission vs. hospital admission or exclusive ED care, according to study results published in BMC Pulmonary Medicine.

The American Thoracic Society International Conference will be held May 19 to 24 in Washington, D.C., with a broad focus on advocacy and global health in many different forms.

Wearing a KF80 mask while exercising and performing daily activities did not impact oxygenation and hemodynamic factors in adults with mild to moderate COPD, according to study results published in Annals of the American Thoracic Society.

The FDA on Wednesday approved the world’s first vaccine against respiratory syncytial virus, which followed years of failed attempts by scientists to develop one.